Top Story Archives - Children's Tumor Foundation

Graphical abstract from The New England Journal of Medicine showing the effects of Brigatinib in NF2-related Schwannomatosis, indicating a decrease in tumor volume for various target tumors.

Collaborations & Partnerships NF2-SWN Press Release Publications Science & Research Top Story Top Story EU

Brigatinib Shows Promise for NF2-SWN: A Direct Result of CTF’s Synodos Initiative

Global NF Conference NF1 NF2-SWN Press Release Science & Research SWN Top Story Top Story EU

Children’s Tumor Foundation Presents the 2024 Global NF Conference in Brussels: Shaping What’s Next for NF

Advocacy Top Story

House Proposes $25 Million for NF Research

Awards & Grants NF Summit Top Story Top Story EU

Make NF Visible Recognition Awards 2024

Collage of diverse individuals wearing blue shirts with "fight nf" logos, promoting neurofibromatosis research awareness.

Awareness Featured Top Story Top Story EU Video

Make NF Research Visible: Video

Featured EU NF1 Pharma Top Story Video

CTF and NFlection Present Webinar on NFX-179 Topical Gel Results